Trials / Terminated
TerminatedNCT00899951
Studying Fentanyl in Patients With Cancer
Pharmacokinetics of Continuous Infusion Fentanyl in Cancer Patients
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 2 (actual)
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
RATIONALE: Studying blood samples from cancer patients undergoing pain treatment in the laboratory may help doctors learn more about how pain drugs work in the body. It may also help doctors predict how patients will respond to treatment. PURPOSE: This research study is looking at fentanyl in patients with cancer.
Detailed description
OBJECTIVES: * To describe the pharmacokinetics of prolonged intravenous infusions of fentanyl citrate in adult patients with cancer. OUTLINE: Patients undergo blood sample collection before and after discontinuation of fentanyl citrate therapy (10 days total). Pharmacokinetic analysis is performed on the samples.
Conditions
- Brain and Central Nervous System Tumors
- Chronic Myeloproliferative Disorders
- Leukemia
- Lymphoma
- Lymphoproliferative Disorder
- Multiple Myeloma and Plasma Cell Neoplasm
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Neoplasms
- Pain
- Precancerous Condition
- Unspecified Adult Solid Tumor, Protocol Specific
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | fentanyl citrate | |
| OTHER | pharmacological study |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2009-05-12
- Last updated
- 2013-04-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00899951. Inclusion in this directory is not an endorsement.